170 related articles for article (PubMed ID: 22129908)
1. Hepatoregenerative role of bone morphogenetic protein-9.
Sosa I; Cvijanovic O; Celic T; Cuculic D; Crncevic-Orlic Z; Vukelic L; Zoricic Cvek S; Dudaric L; Bosnar A; Bobinac D
Med Sci Monit; 2011 Dec; 17(12):HY33-5. PubMed ID: 22129908
[TBL] [Abstract][Full Text] [Related]
2. Putative hormone with anti-obesogenic and insulin-sensitizing effect.
Sosa I; Grubesic A
Int J Immunopathol Pharmacol; 2016 Mar; 29(1):147-8. PubMed ID: 26714521
[TBL] [Abstract][Full Text] [Related]
3. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance.
Caperuto LC; Anhê GF; Cambiaghi TD; Akamine EH; do Carmo Buonfiglio D; Cipolla-Neto J; Curi R; Bordin S
Endocrinology; 2008 Dec; 149(12):6326-35. PubMed ID: 18703636
[TBL] [Abstract][Full Text] [Related]
4. BMP-9 interferes with liver regeneration and promotes liver fibrosis.
Breitkopf-Heinlein K; Meyer C; König C; Gaitantzi H; Addante A; Thomas M; Wiercinska E; Cai C; Li Q; Wan F; Hellerbrand C; Valous NA; Hahnel M; Ehlting C; Bode JG; Müller-Bohl S; Klingmüller U; Altenöder J; Ilkavets I; Goumans MJ; Hawinkels LJ; Lee SJ; Wieland M; Mogler C; Ebert MP; Herrera B; Augustin H; Sánchez A; Dooley S; Ten Dijke P
Gut; 2017 May; 66(5):939-954. PubMed ID: 28336518
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
6. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.
Herrera B; Dooley S; Breitkopf-Heinlein K
Int J Mol Sci; 2014 Mar; 15(4):5199-220. PubMed ID: 24670474
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of bone morphogenetic protein-9 in glucose and lipid homeostasis.
Wang Y; Ma C; Sun T; Ren L
J Physiol Biochem; 2020 Nov; 76(4):503-512. PubMed ID: 32808114
[TBL] [Abstract][Full Text] [Related]
8. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF).
Pegorier S; Campbell GA; Kay AB; Lloyd CM
Respir Res; 2010 Jun; 11(1):85. PubMed ID: 20573231
[TBL] [Abstract][Full Text] [Related]
10. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-7 (BMP-7) augments insulin sensitivity in mice with type II diabetes mellitus by potentiating PI3K/AKT pathway.
Chattopadhyay T; Singh RR; Gupta S; Surolia A
Biofactors; 2017 Mar; 43(2):195-209. PubMed ID: 28186649
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 7 suppresses the progression of hepatic fibrosis and regulates the expression of gremlin and transforming growth factor β1.
Yang T; Chen SL; Lu XJ; Shen CY; Liu Y; Chen YP
Mol Med Rep; 2012 Jul; 6(1):246-52. PubMed ID: 22552821
[TBL] [Abstract][Full Text] [Related]
13. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
Brown MA; Zhao Q; Baker KA; Naik C; Chen C; Pukac L; Singh M; Tsareva T; Parice Y; Mahoney A; Roschke V; Sanyal I; Choe S
J Biol Chem; 2005 Jul; 280(26):25111-8. PubMed ID: 15851468
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1.
Knittel T; Fellmer P; Müller L; Ramadori G
Exp Cell Res; 1997 May; 232(2):263-9. PubMed ID: 9168801
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes.
Takahashi T; Morris EA; Trippel SB
Int J Mol Med; 2007 Jul; 20(1):53-7. PubMed ID: 17549388
[TBL] [Abstract][Full Text] [Related]
17. Basolateral BMP signaling in polarized epithelial cells.
Saitoh M; Shirakihara T; Fukasawa A; Horiguchi K; Sakamoto K; Sugiya H; Beppu H; Fujita Y; Morita I; Miyazono K; Miyazawa K
PLoS One; 2013; 8(5):e62659. PubMed ID: 23675417
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
19. Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes.
Drexler S; Cai C; Hartmann AL; Moch D; Gaitantzi H; Ney T; Kraemer M; Chu Y; Zheng Y; Rahbari M; Treffs A; Reiser A; Lenoir B; Valous NA; Jäger D; Birgin E; Sawant TA; Li Q; Xu K; Dong L; Otto M; Itzel T; Teufel A; Gretz N; Hawinkels LJAC; Sánchez A; Herrera B; Schubert R; Moshage H; Reissfelder C; Ebert MPA; Rahbari NN; Breitkopf-Heinlein K
Mol Cell Endocrinol; 2023 Jun; 570():111934. PubMed ID: 37085108
[TBL] [Abstract][Full Text] [Related]
20. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
